2021, Number 1
Safety and feasibility of laparoscopic staging in endometrial cancer
Language: Spanish
References: 36
Page: 1-15
PDF size: 178.40 Kb.
ABSTRACT
Introduction: Surgical staging in endometrial cancer is part of the study to determine tumor extent.Objective: To describe the safety and feasibility of laparoscopic staging in endometrial cancer.
Methods: A descriptive, prospective, observational study was conducted in 70 patients with endometrial cancer, who were staged by laparoscopic surgery according to the rules of the American Joint Committee on Cancer and the International Federation of Gynecology in the period between February 1, 2012 and November 30, 2017 at the National Center for Minimally Invasive Surgery in Havana, Cuba.
Methods: A descriptive, prospective, observational study was conducted in 70 patients with endometrial cancer, who were staged by laparoscopic surgery according to the rules of the American Joint Committee on Cancer and the International Federation of Gynecology from February 1, 2012 to November 30, 2017 at the National Center for Minimally Invasive Surgery in Havana, Cuba. Results: The mean age was 63 years. The mean surgical time and blood loss was 201 minutes and 79.3 milliliters, respectively. The mean number of pelvic nodes was 16.9 and 3.7para-aortic nodes were removed. No patient had complications and there were no complications that led to conversion to laparotomy. The hospital stay was between 24 and 48 hours.
Conclusions: Laparoscopic staging in endometrial cancer is a feasible and safe technique, which enables pelvic lymph node dissection, reduction of surgical time, intraoperative bleeding, intra and postoperative complications, and decreased hospital stay.
REFERENCES
Acholonu UC, Chang-Jackson S-CR, Radjabi AR, Nezhat FR. Laparoscopy for themanagement of early-stage endometrial cancer: from experimental to standardof care. J Minim Invasive Gynecol. 2012 [acceso 11/04/2018];19(4):434-42.Disponible en: https://www.clinicalkey.es/#!/content/playContent/1-s2.0-S1553465012001021
Bergstrom J, Aloisi A, Armbruster S, Yen T-T, Casarin J, Leitao MM, et al.Minimally invasive hysterectomy surgery rates for endometrial cancer performedat National Comprehensive Cancer Network (NCCN) Centers. Gynecol Oncol. 2018[acceso 16/05/2018];148(3):480-4. Disponible en:https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0090825818300027
Bogani G, Cromi A, Uccella S, Serati M, Casarin J, Pinelli C, et al.Perioperative and long-term outcomes of laparoscopic, open abdominal, andvaginal surgery for endometrial cancer in patients aged 80 years or older. Int JGynecol Cancer. 2014 [acceso 16/05/2018];24(5):894-900. Disponible en:https://ijgc.bmj.com/content/24/5/894
Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, et al. Quality of lifeafter total laparoscopic hysterectomy versus total abdominal hysterectomy forstage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. 2010[acceso 16/05/2018];11(8):772-80. Disponible en:https://www.clinicalkey.es/#!/content/journal/1-s2.0-S1470204510701455
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS,et al. Laparoscopy compared with laparotomy for comprehensive surgical stagingof uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009[acceso 14/04/2018];27(32):5331-6. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773219/
Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, LedermannJ, et al. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer:diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016 [acceso13/04/2018];26(1):2-30. Disponible en:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679344/
Bray F, Loos AH, Oostindier M, Weiderpass E. Geographic and temporalvariations in cancer of the corpus uteri: incidence and mortality in pre- andpostmenopausal women in Europe. Int J Cancer. 2005 [acceso15/04/2018];117(1):123-31. Disponible en:https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.21099
Díaz Ortega I, Martínez Martínez-Pinillo ÁF, Morera Pérez M, Barreras González JE,Montero León JF, Amigó de Quesada M. Estadiamiento videolaparoscópico en eladenocarcinoma de endometrio. Rev Cubana Obst Ginecol. 2014 [acceso16/05/2018];40(1):58-67. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2014000100007
Malzoni M, Tinelli R, Cosentino F, Perone C, Rasile M, Iuzzolino D, et al. Totallaparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy forearly-stage endometrial cancer: a prospective randomized study. Gynecol Oncol. 2009[acceso 12/04/2018];112(1):126-33. Disponible en:https://www.clinicalkey.es/#!/content/journal/1-s2.0-S0090825808006501
Bijen CBM, Briët JM, de Bock GH, Arts HJG, Bergsma-Kadijk JA, Mourits MJE. Totallaparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patientswith early stage endometrial cancer: A randomized multicenter study. BMC Cancer.2009 [acceso 05/06/2018];9:23. Disponible en:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630311/
Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al.Retrospective analysis of selective lymphadenectomy in apparent early-stageendometrial cancer. J Clin Oncol. 2005;23(16):3668-75. DOI:https://ascopubs.org/doi/10.1200/JCO.2005.04.144?url_ver=Z39.882003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&cookieSet=1
Bristow RE, Palis BE, Chi DS, Cliby WA. The National Cancer Database report onadvanced-stage epithelial ovarian cancer: impact of hospital surgical case volume onoverall survival and surgical treatment paradigm. Gynecol Oncol. 2010 [acceso03/04/2018];118(3):262-7. Disponible en:https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0S0090825810004087.pdf?locale=es_ES&searchIndex=
Dahm-Kahler P, Palmqvist C, Staf C, Holmberg E, Johannesson L. Centralizedprimary care of advanced ovarian cancer improves complete cytoreduction andsurvival. A population-based cohort study. Gynecol Oncol. 2016 [acceso03/04/2018];142(2):211-6. Disponible en:https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0090825816307545.pdf?locale=es_ES&searchIndex=
Penner KR, Fleming ND, Barlavi L, Axtell AE, Lentz SE. Same-day discharge isfeasible and safe in patients undergoing minimally invasive staging for gynecologicmalignancies. Am J Obstet Gynecol. 2015 [acceso 18/04/2018];212(2):186:e1-8.Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0002937814008412.pdf?locale=es_ES&searchIndex=
Fader AN, Weise RM, Sinno AK, Tanner EJ 3rd, Borah BJ, Moriarty JP, et al.Utilization of minimally invasive surgery in endometrial cancer care: a qualityand cost disparity. Obstet Gynecol. 2016 [acceso 03/04/2018];127(1):91-100.Disponible en:https://journals.lww.com/greenjournal/Fulltext/2016/01000/Utilization_of_Minimally_Invasive_Surgery_in.14.aspx
Mannschreck D, Matsuno RK, Moriarty JP, Borah BJ, Dowdy SC, Tanner EJ, etal. Disparities in surgical care among women with endometrial cancer. ObstetGynecol. 2016 [acceso 03/04/2018];128(3):526-34. Disponible en:https://journals.lww.com/greenjournal/Fulltext/2016/09000/Disparities_in_Surgical_Care_Among_Women_With.15.aspx